interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Triptorelin Pamoate

Generic competition · all medicines · read 12 November 2026

Is there a generic of Triptorelin Pamoate, and who makes it?

Triptorelin Pamoate appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 2 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Triptorelin Pamoate2 dosage-form groups in the Orange Book
0generic makers listed
  1. Triptorelin Pamoate appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 2 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Injectable, Intramuscular

Brand listed, no generic listed as marketed

Brand listed as marketed: Trelstar. No generic is listed as marketed.

200020052010201520202025203001brand 2000data datePatent 10166181 listed to expire 30 June 2029
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 30 June 2029Patent 10166181 drug product

For Suspension, Extended Release, Intramuscular

Brand listed, no generic listed as marketed

Brand listed as marketed: Triptodur Kit. No generic is listed as marketed.

201520202025203001brand 2017data datePatent 10166181 listed to expire 30 June 2029
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 30 June 2029Patent 10166181 drug product

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.